Sustained delivery of therapeutic concentrations of human clotting factor IX – a comparison of adenoviral and AAV vectors administered in utero

2002

Schneider, H., Muhle, C., Douar, A.M., Waddington, S., Jiang, Q.J., Von der Mark, K., Coutelle, C. and Rascher, W.:

J Gene Med 4 (2002) 46-53.